Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

4.900 USD +0.400 (+8.89%)
Official Closing Price Updated: 7:56 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Genprex Provides Clinical and Corporate Update for Third Quarter 2018
Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced a clinical and... 
From Business Wire News Releases
The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags MGTA STIM VBLT
From Benzinga
Genprex Appoints Jan Stevens, RN, as Vice President of Clinical Operations
Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today the appointment of... 
From Business Wire News Releases
The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags LOGC PRTK XBI
From Benzinga
The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program
Here's a roundup of top developments in the biotech space over the last 24 hours. Amid the market mayhem, no biotech or medical ... 
Tags TBIO FDA JNCE
From Benzinga
The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags LJPC ONCY Trading Ideas
From Benzinga
The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags TTNP IBB GWPH
From Benzinga
The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ... 
Tags News NVLN MRK
From Benzinga
Genprex to Present at Upcoming Investor and Industry Conferences
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that the management... 
From Business Wire News Releases
Analysts Forecast 22% Gains Ahead For IWC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Genprex™ Taps Aldevron to Supply TUSC2 Plasmid DNA for Oncoprex Clinical Development Program
Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, has signed an agreement with... 
From Business Wire News Releases
The Week Ahead: Nike Earnings, FDA Debates E-Cig Industry, SurveyMonkey IPOs
Below is a list of notable corporate events for the week beginning Sept. 24. Note, this list is not comprehensive and all dates are ... 
Tags General ARDS OKE
From Benzinga
44 Biggest Movers From Friday
Gainers Qutoutiao Inc. (NASDAQ: QTT) shares surged 128.14 percent to close at $15.97 on Friday. Qutoutiao announced an initial ... 
Tags Communications Equipment Trading Ideas ONCY
From Benzinga
32 Stocks Moving In Friday's Mid-Day Session
Gainers Frequency Electronics, Inc. (NASDAQ: FEIM) shares gained 17 percent to $9.21. Frequency Electronics reported Q1 net ... 
Tags TMSR CODX SGBX
From Benzinga
Benzinga's Top Upgrades, Downgrades For September 14, 2018
Top Upgrades Citigroup upgraded Corning Incorporated (NYSE: GLW) from Neutral to Buy. Corning shares rose 2.37 percent to $35.89 ... 
Tags HP ARGX Downgrades
From Benzinga
26 Stocks Moving In Tuesday's Pre-Market Session
Gainers Genprex, Inc. (NASDAQ: GNPX) rose 17.7 percent to $3.00 in pre-market trading. Restoration Robotics, Inc. (NASDAQ: HAIR) ... 
Tags AGMH ING WPP
From Benzinga
40 Biggest Movers From Yesterday
Gainers Affimed N.V. (NASDAQ: AFMD) shares climbed 246.88 percent to close at $5.55 on Tuesday after the clinical stage ... 
Tags REPL BRKS Benzinga
From Benzinga
Genprex Amends Options to License Additional Cancer Fighting Technologies from the University of Texas MD Anderson Cancer Center
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it has entered... 
From Business Wire News Releases
The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech Stocks hitting ... 
Tags AKCA INSP ATRC
From Benzinga
The Daily Biotech Pulse: Novartis Breast Cancer Trial Meets Endpoint, Medpace's Offering, Dexcom Buys TypeZero
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags CO FDA KALV
From Benzinga
Genprex to Present at Upcoming Investor Conferences
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that company... 
From Business Wire News Releases
Genprex Provides Clinical and Corporate Update for Second Quarter 2018
Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced a clinical and... 
From Business Wire News Releases
Genprex Updates Agreement with University of Texas MD Anderson Cancer Center to Resume Patient Enrollment in Phase I/II Study Evaluating Oncoprex/Erlotinib Combination Therapy in Non-Small Cell Lung C
Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that it has amended... 
From Business Wire News Releases
28 Stocks Moving In Monday's Pre-Market Session
Gainers Avalon Holdings Corporation (NYSE: AWX) rose 93.2 percent to $19.80 in pre-market trading after climbing 80.14 percent on ... 
Tags Pre/Market Outlook Market News USFD
From Benzinga
62 Biggest Movers From Friday
Gainers SSLJ.com Limited (NASDAQ: SSLJ) shares climbed 125.79 percent to close at $1.35 on Friday. Avalon Holdings Corporation ... 
Tags EA MTSL XBIO
From Benzinga
Benzinga's Biggest Movers For The Week Of July 23, 2018
The data presented below was compiled using a Screener widget and a Newsfeed widget on the Benzinga Pro platform. The Screener is ... 
Tags Trading Ideas SVU SXE
From Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Gainers SSLJ.com Limited (NASDAQ: SSLJ) shares jumped 120.8 percent to $1.32. Cherokee Inc. (NASDAQ: CHKE) shares rose 29.5 ... 
Tags NCR Movers Losers
From Benzinga
Genprex Enters Agreement with the University of Texas MD Anderson Cancer Center to Study Oncoprex in Combination with Immunotherapies
Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, has entered a Sponsored Research... 
From Business Wire News Releases
Genprex To Present At The Singular Research Summer Solstice 2018 Conference
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that Rodney Varner,... 
From PR Newswire
Diamond Equity Research Initiates Coverage on Genprex Inc. (NASDAQ: GNPX) with a Valuation of $13 Per Share
via NetworkWire – Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies has initiated coverage of Genprex Inc.... 
From GlobeNewswire News Releases
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.